basal-bolus insulin therapy
Showing 1 - 25 of >10,000
Type 2 Diabetes Treated With Insulin Trial (t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM, Standard
Not yet recruiting
- Type 2 Diabetes Treated With Insulin
- t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
- Standard Therapy plus continuous glucose monitoring (CGM)
- (no location specified)
Mar 14, 2023
Type 2 Diabetes Treated With Insulin Trial (premixed insulin therapy, basal bolus insulin therapy)
Completed
- Type 2 Diabetes Treated With Insulin
- premixed insulin therapy
- basal bolus insulin therapy
- (no location specified)
Feb 1, 2021
Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)
Recruiting
- Diabetes Mellitus, Type 2 Treated With Insulin
- insulin degludec + liraglutide
- Insulin Glargine - Insulin Aspart
-
Bogotá, ColombiaHospital Universitario San Ignacio
Mar 2, 2023
Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII) Trial in Montpellier (Training course to
Terminated
- Type 1 Diabetes
- +2 more
- Training course to functional insulin therapy
- Usual diabetes management.
-
Montpellier, FranceLapeyronie Hospital - CHU de Montpellier
Dec 9, 2021
Type 1 Diabetes Trial (Semaglutide weekly injection)
Not yet recruiting
- Type 1 Diabetes
- Semaglutide weekly injection
- (no location specified)
Sep 21, 2023
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus
Not yet recruiting
- Type 1 Diabetes
- premix insulin human isophane suspension and insulin human
- Humulin N plus Humulin R
-
Bobo-Dioulasso, Houet, Burkina Faso
- +2 more
Mar 12, 2023
Diabetes, Diabetes, Type 2, Diabetes, Type 1 Trial in Prague, Montpellier, Padova (Personalized Glucose Predictive and Therapy
Completed
- Diabetes Mellitus
- +2 more
- Personalized Glucose Predictive and Therapy Advisory System (DIAdvisor)
-
Prague, Czechia
- +2 more
Oct 18, 2021
Diabetes, Type 2 Trial (Empagliflozin 25 MG, INS)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin 25 MG
- INS
- (no location specified)
Jul 19, 2022
Insulia® Tool in Type 2 Diabetes Treated With Basal Insulin
Recruiting
- Type 2 Diabetes Mellitus
-
Corbeil-essonnes Cedex, FranceCentre Hospitalier Sud Francilien
Nov 21, 2022
Type 1 Diabetes Trial in Montreal (Sensor augmented MDI therapy plus mobile application)
Recruiting
- Type 1 Diabetes
- Sensor augmented MDI therapy plus mobile application
-
Montreal, Quebec, CanadaClinique Médicale Hygea
Apr 19, 2022
Type 2 Diabetes Trial in Chicago (insulin aspart, insulin detemir)
Completed
- Type 2 Diabetes Mellitus
- insulin aspart
- insulin detemir
-
Chicago, IllinoisRush University Medical Center
Jan 31, 2022
Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy
Active, not recruiting
- Diabetes Mellitus Type 2 - Insulin-Treated
- Smartphone application and web portal
- Standard Insulin Therapy Education
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jan 6, 2023
Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE (HOE901)
- +5 more
-
China, ChinaCHINA
Apr 21, 2022
Type 2 Diabetes Trial in Tübingen (Dapagliflozin 10 mg + Saxagliptin 5 mg, Placebo 1 10 mg + Placebo 2 5 mg)
Terminated
- Type 2 Diabetes
- Dapagliflozin 10 mg + Saxagliptin 5 mg
- Placebo 1 10 mg + Placebo 2 5 mg
-
Tübingen, GermanyUniversity Hospital Tübingen
Feb 7, 2020
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Type 2 Diabetes Trial in Naples (IDegLira, IGlarLixi, Insulin/Canaglifozin)
Completed
- Type 2 Diabetes
- IDegLira
- +5 more
-
Naples, ItalyUnit of Endocrinology and Metabolic Diseases
Oct 20, 2020
![](/image/sponsor/hospital_de_especialidades_centro_medico_nacional_"la_raza"_instituto_mexicano_del_seguro_social)
Type 2 Diabetes Trial in Mexico City (Sitagliptin 100mg, Glargine, Lispro)
Recruiting
- Type 2 Diabetes
- Sitagliptin 100mg
- +2 more
-
Mexico City, MexicoDivisión de Investigación en Salud, Hospital de Especialidades,
Oct 11, 2022
Type 1 Diabetes Trial in Montreal (Continous exercise, Interval exercise, Reduction of basal insulin by 40%)
Recruiting
- Type 1 Diabetes Mellitus
- Continous exercise
- +3 more
-
Montreal, Quebec, Canada
- +1 more
Jan 12, 2022
Diabetes, Type 2 Diabetes Trial in Manhasset (FreeStyle Libre)
Completed
- Diabetes
- Type 2 Diabetes
- FreeStyle Libre
-
Manhasset, New YorkNorthwell Health North Shore University Hospital
Jan 7, 2022
Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes Trial in Chicago (NPH Insulin, glargine, Insulin Aspart)
Terminated
- Hyperglycemia Steroid-induced
- Insulin Resistance, Diabetes
- NPH Insulin
- +2 more
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine
Aug 25, 2020
Type2diabetes, Coronary Artery Disease Trial in Gurgaon (Dapagliflozin, Glargine)
Recruiting
- Type2diabetes
- Coronary Artery Disease
-
Gurgaon, Haryana, IndiaDivision Of Endocrinology and Diabetes, Medanta The Medicity
Jul 29, 2022
Type 2 Diabetes Trial in León (NPH insulin, Glargine and Lispro insulin)
Completed
- Type 2 Diabetes Mellitus
- NPH insulin
- Glargine and Lispro insulin
-
León, Guanajuato, MexicoHospital General de León
Nov 3, 2021
Stratification of Type 2 Diabetes Microvascular Complications
Recruiting
- Type 2 Diabetes
- +4 more
- Diabetes Microvascular Complication Tests
-
Singapore, SingaporeSingapore General Hospital
Mar 14, 2023